Scott J. Hebbring

7.8k total citations
67 papers, 2.0k citations indexed

About

Scott J. Hebbring is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Scott J. Hebbring has authored 67 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 31 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Scott J. Hebbring's work include Genetic Associations and Epidemiology (20 papers), Genomics and Rare Diseases (8 papers) and Epigenetics and DNA Methylation (7 papers). Scott J. Hebbring is often cited by papers focused on Genetic Associations and Epidemiology (20 papers), Genomics and Rare Diseases (8 papers) and Epigenetics and DNA Methylation (7 papers). Scott J. Hebbring collaborates with scholars based in United States, China and Japan. Scott J. Hebbring's co-authors include Daniel J. Schaid, Stephen N. Thibodeau, Julie M. Cunningham, Shannon K. McDonnell, Richard M. Weinshilboum, Gregory D. Jenkins, Michael L. Blute, Steven J. Jacobsen, Yuan Ji and Murray H. Brilliant and has published in prestigious journals such as Nature Communications, Nature Genetics and Bioinformatics.

In The Last Decade

Scott J. Hebbring

62 papers receiving 2.0k citations

Peers

Countries citing papers authored by Scott J. Hebbring

Since Specialization

Citations

This map shows the geographic impact of Scott J. Hebbring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott J. Hebbring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott J. Hebbring more than expected).

Fields of papers citing papers by Scott J. Hebbring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott J. Hebbring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott J. Hebbring. The network helps show where Scott J. Hebbring may publish in the future.

Co-authorship network of co-authors of Scott J. Hebbring

This figure shows the co-authorship network connecting the top 25 collaborators of Scott J. Hebbring. A scholar is included among the top collaborators of Scott J. Hebbring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott J. Hebbring. Scott J. Hebbring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway 2025 ·Advanced Science ·Zhi Wen, Yidan Wang, (unknown), (unknown), (unknown), Terrie Kitchner, (unknown), Sung Hoon Kim, (unknown), (unknown), (unknown), (unknown), John A. Katzenellenbogen, Scott J. Hebbring, Benita S. Katzenellenbogen, Siegfried Janz, Adedayo A. Onitilo	0
2	Exploring prognostic implications of miRNA signatures and telomere maintenance genes in kidney cancer 2024 ·PubMed ·Srinivasulu Yerukala Sathipati, Sohyun Jeong, Param Sharma, John Mayer, Rohit Sharma, Shinn‐Ying Ho, Scott J. Hebbring	0
3	Abstract 4892: MicroRNA signature and telomere genes in kidney cancer survival 2024 ·Cancer Research ·Srinivasulu Yerukala Sathipati, Rohit Sharma, Scott J. Hebbring	1
4	Estimating the efficacy of pharmacogenomics over a lifetime 2023 ·Frontiers in Medicine ·Zhan Ye, John Mayer, (unknown), Terrie Kitchner, Richard A. Dart, Murray H. Brilliant, Scott J. Hebbring	4
5	Kidney failure in Bardet – Biedl syndrome 2022 ·Clinical Genetics ·(unknown), Anthony D. Krentz, (unknown), (unknown), Jeremy Pomeroy, Scott J. Hebbring, Robert Haws	22
6	Cardiac Anomalies in Liveborn and Stillborn Monochorionic Twins 2020 ·Clinical Medicine & Research ·Elizabeth McPherson, (unknown), Scott J. Hebbring	4
7	Genomic and Phenomic Research in the 21st Century 2018 ·Trends in Genetics ·Scott J. Hebbring	15
8	Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants 2017 ·Science Translational Medicine ·Jason H. Karnes, Lisa Bastarache, Christian M. Shaffer, Silvana Gaudieri, Yaomin Xu, Andrew M. Glazer, Jonathan D. Mosley, Shilin Zhao, Soumya Raychaudhuri, S. Mallal, Zhan Ye, John Mayer, Murray H. Brilliant, Scott J. Hebbring, Dan M. Roden, Elizabeth J. Phillips, Joshua C. Denny	74
9	Applying family analyses to electronic health records to facilitate genetic research 2017 ·Bioinformatics ·(unknown), Robert C. Elston, Guilherme J. M. Rosa, John Mayer, Zhan Ye, Terrie Kitchner, Murray H. Brilliant, David Page, Scott J. Hebbring	6
10	Identifying genetically driven clinical phenotypes using linear mixed models 2016 ·Nature Communications ·Jonathan D. Mosley, John S. Witte, Emma K. Larkin, Lisa Bastarache, Christian M. Shaffer, Jason H. Karnes, C. Michael Stein, Elizabeth J. Phillips, Scott J. Hebbring, Murray H. Brilliant, John Mayer, Zhan Ye, Dan M. Roden, Joshua C. Denny	8
11	Phenome-wide association studies (PheWASs) for functional variants 2014 ·European Journal of Human Genetics ·Zhan Ye, John Mayer, Lynn Ivacic, Zhiyi Zhou, Min He, Steven J. Schrodi, David Page, Murray H. Brilliant, Scott J. Hebbring	35
12	A PheWAS approach in studying HLA-DRB11501 2013 ·Genes and Immunity* ·Scott J. Hebbring, Steven J. Schrodi, Zhenyu Ye, Zhiyi Zhou, David Page, Murray H. Brilliant	64
13	Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics 2012 ·The Pharmacogenomics Journal ·Yuan Ji, (unknown), Scott J. Hebbring, Yubo Chai, G. Douglas Jenkins, (unknown), Karen Snyder, Maureen S. Drews, Zeruesenay Desta, David A. Flockhart, Taisei Mushiroda, Michiaki Kubo, Yoshimasa Nakamura, Naoyuki Kamatani, Daniel J. Schaid, Richard M. Weinshilboum, David A. Mrazek	52
14	Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation 2012 ·Pharmacogenetics and Genomics ·Ryan Abo, Scott J. Hebbring, Yuan Ji, Hongjie Zhu, (unknown), Anthony Batzler, Gregory D. Jenkins, Joanna M. Biernacka, Karen Snyder, Maureen S. Drews, Oliver Fiehn, Brooke L. Fridley, Daniel J. Schaid, Naoyuki Kamatani, Yusuke Nakamura, Michiaki Kubo, Taisei Mushiroda, Rima Kaddurah‐Daouk, David A. Mrazek, Richard M. Weinshilboum	43
15	Human Liver Methionine Cycle: MAT1A and GNMT Gene Resequencing, Functional Genomics, and Hepatic Genotype-Phenotype Correlation 2012 ·Drug Metabolism and Disposition ·Yuan Ji, (unknown), Yubo Chai, Scott J. Hebbring, Gregory D. Jenkins, Ryan Abo, Yi Peng, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Xiaoshan Chai, Jianping Zhang, Brooke L. Fridley, Vivien C. Yee, Eric D. Wieben, Richard M. Weinshilboum	15
16	Utilizing Genotype Imputation for the Augmentation of Sequence Data 2010 ·PLoS ONE ·Brooke L. Fridley, Gregory D. Jenkins, (unknown), Scott J. Hebbring, Robert R. Freimuth	17
17	Betaine-homocysteine methyltransferase: Human liver genotype–phenotype correlation 2010 ·Molecular Genetics and Metabolism ·QiPing Feng, Krishna R. Kalari, Brooke L. Fridley, Gregory D. Jenkins, Yuan Ji, Ryan Abo, Scott J. Hebbring, Jianping Zhang, Monica D. Nye, J. Steven Leeder, Richard M. Weinshilboum	40
18	Glutathione S -Transferase T1 and M1: Gene Sequence Variation and Functional Genomics 2007 ·Clinical Cancer Research ·Ann M. Moyer, Oreste E. Salavaggione, Scott J. Hebbring, Irene Moon, Michelle A.T. Hildebrandt, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben, Richard M. Weinshilboum	58
19	Human SULT1A1 gene: copy number differences and functional implications 2006 ·Human Molecular Genetics ·Scott J. Hebbring, Araba A. Adjei, (unknown), Gregory D. Jenkins, Jianping Zhang, Julie M. Cunningham, Daniel J. Schaid, Richard M. Weinshilboum, Stephen N. Thibodeau	94
20	Allelic Imbalance of 8p Indicates Poor Survival in Gastric Cancer 2004 ·Journal of Molecular Diagnostics ·Amy J. French, Gina R. Petroni, (unknown), Mark E. Smolkin, Eric A. Bissonette, Franco Roviello, Jeffrey C. Harper, Benjamin Koch, Sarah Anderson, Scott J. Hebbring, Steven M. Powell	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact